Antibody

This page contains news and, when available, background information, on Antibody. Links on this site lead to other sites on the web.


Antibody - Any of the body globulins that combine specifically with antigens and neutralize toxins, agglutinate bacteria or cells, and precipitate soluble antigens.
[NABIR Bioremediation Glossary]

News archive for Antibody:

XOMA to Announce Second Quarter 2008 Financial Results and Host ...  -  04 Aug 2008
MarketWatch...a leader in the discovery and development of antibody therapeutics, announced that the Company will host a conference call and webcast on Thursday,

Amyloid beta mAb shows safety and perhaps efficacy in Alzheimer's ...  -  04 Aug 2008
Medicexchange,Phase 2 results presented this week at the International Conference on Alzheimer's Disease (ICAD) 2008 in Chicago show that a monoclonal antibody to amyloid

Penn researchers find a new role for a 'Foxy Old Gene'  -  04 Aug 2008
Hindu,First, in the two-step assay, chromatin (DNA and protein) was extracted from liver cells and an antibody specific for FOXA2 was used to recognize the

GlaxoSmithKline and Genmab: Breakthrough in Leukemia Treatment  -  04 Aug 2008
TopNews,...“Genmab is now on its way to filling the first ever marketing application for an antibody and the team was looking forward to continuing the work with GSK,�

US HIV incidence 40% higher than previous estimates, new test shows  -  04 Aug 2008
Aidsmap,Standard HIV antibody tests show whether a person has the virus, but cannot determine how recently infection occurred. Furthermore, due to confidentiality

ImClone Says Bristol-Myers Bid Is Too Low  -  04 Aug 2008
New York Times,Bristol-Myers may have gained information on IMC-11F8, a pipeline antibody under development that ImClone says may have a “significant competitive effect�

Intellect Neurosciences, Inc. Obtains Pivotal European Patent ...  -  Jul 31, 2008
MarketWatchThe Company retains the ability to grant additional licenses under its ANTISENILIN(R) monoclonal antibody technology invented by Dr. Daniel Chain,

Lilly says Alzheimer's antibody drug safe  -  Jul 30, 2008
ReutersN: Quote, Profile, Research) antibody drug for Alzheimer's disease was safe and appeared to be dissolving sticky brain plaques, but a three-month study was

Strategic Diagnostics' Q2 Revenues Dip on Antibody Sales Decline  -  Aug 1, 2008
GenomeWeb News (subscription),Its Genomic Antibody Technology sales rose 121 percent. "The second quarter was a challenge for the company due to a shortfall in business from key bulk

GTC Biotherapeutics to Announce Second Quarter 2008 Earnings on ...  -  Jul 31, 2008
MarketWatchGTC also has a monoclonal antibody portfolio that includes a monoclonal antibody to CD20 and a monoclonal antibody to CD137.

ICAD: Monoclonal Antibody that Binds to Amyloid Found Safe in ...  -  Jul 31, 2008
MedPage Today,By Todd Neale, Staff Writer, MedPage Today CHICAGO, July 31 -- An investigational monoclonal antibody that binds to beta-amyloid was well tolerated by

Dyax Corp. and AVEO Pharmaceuticals Announce Antibody Library ...  -  Jul 22, 2008
MarketWatch...and AVEO Pharmaceuticals, Inc. announced today that Dyax has granted AVEO a non-exclusive license to Dyax's proprietary antibody phage display libraries for

Seattle Genetics Initiates SGN-70 Phase I Clinical Trial  -  Jul 31, 2008
MarketWatch...announced today that it has initiated a phase I clinical trial of SGN-70, a humanized monoclonal antibody targeting CD70 that is being developed as an

Roche starts acquisition process of ARIUS to gain access to new ...  -  Jul 23, 2008
FOXBusinessARIUS is the developer of a proprietary antibody platform called FunctionFIRST(TM), which rapidly identifies and selects antibodies based on their

Methods for Protein A and G antibody  -  Jul 29, 2008
Laboratory Talk,The system provides a great solution for researchers who need to purify liters of monoclonal antibody from very diluted hybridoma culture and generates pure

Goodwin Biotechnology's Manufactured Melanin-Binding Antibody Used ...  -  Jul 21, 2008
MarketWatchPain Therapeutics reported that top-line results of the Phase I trial indicate that the antibody binds to melanoma tumor sites, as evidenced by powerful

Medarex Highlights Strength in Antibody Development and Underlying ...  -  Jul 10, 2008
Biloxi Sun Herald,By Medarex, Inc. Medarex, Inc. (Nasdaq: MEDX) today provided a detailed overview of the company's strategy, strength in research discovery and antibody

Diverse Approaches to Alzheimer's Therapies Continue to Show ...  -  Jul 30, 2008
MarketWatchResults of a Phase II study of a monoclonal antibody (LY2062430, Lilly) in mild to moderate Alzheimer's. -- Research suggesting that persistent antidementia

Baxter boosted by drug's head start  -  Jul 31, 2008
Chicago Tribune,Indianapolis-based Eli Lilly & Co. said Wednesday it will begin a Phase 3 study next year of its drug, a monoclonal antibody.

Genmab and GlaxoSmithKline Announce Positive Top-Line Results in ...  -  Jul 31, 2008
MarketWatch..."This also represents a significant achievement for Genmab as we now move toward filing of the first marketing applications for a Genmab antibody and we

Genmab Shares Rise as Cancer Treatment Succeeds in New Test  -  Aug 1, 2008
BloombergOfatumumab is a man-made version of an antibody produced by the immune system to fight off infection. The antibody targets the CD20 molecule on B cells,

Strategic Diagnostics Reports Second Quarter 2008 Results  -  Jul 31, 2008
Business Wire (press release),These solid gains were offset by a 50% decline in the Bulk Antibody business. Year-to-date revenues increased 3% to $13.7 million, versus $13.4 million for

MediGene Exercises Option for Anti-L1 Monoclonal Antibody and ...  -  Jul 17, 2008
FOXBusinessThe L1-antibody is currently in the preclinical phase of development. Professor Altevogt's research team at the DKFZ developed the antibodies against L1 and

Cohort study of the association of antibody levels to AMA1, MSP119 ...  -  Jul 29, 2008
7thSpace Interactive (press release),Antigen-specific antibody-mediated immune responses play an important role in natural protection against clinical malaria, but conflicting estimates of this

Genmab surges on successful drug study with Glaxo  -  Aug 1, 2008
ReutersThe companies said late on Thursday the antibody drug met its goal in the study of difficult-to-treat patients with chronic lymphocytic leukaemia (LCC),

Genmab, Glaxo cancer drug beats target in key test  -  Jul 31, 2008
ReutersThe antibody drug met its goal in the study of difficult-to-treat patients with chronic lymphocytic leukaemia (CLL), producing a response rate well in

FDA: Roche's Actemra Appears Effective in Rheumatoid Arthritis  -  Jul 25, 2008
Wall Street JournalIt is a humanized monoclonal antibody -- an antibody produced by a single cell -- and the first to inhibit the interleukin-6, or IL-6, receptor.

Immunomedics Announces Worldwide License and Collaboration ...  -  Jul 14, 2008
MarketWatchConstructed using the same donor frameworks as epratuzumab, the Company's anti-CD22 humanized antibody, veltuzumab is an anti-CD20 monoclonal antibody

Bio-Rad Describes Methods for Protein A Antibody Purification  -  Jul 24, 2008
PharmaLive.com (press release),...“The Profinia™ Protein Purification System Simplifies Antibody Purification with Protein A�. The technical note provides results that demonstrate how

Antibody To Breast Cancer-secreted Protein Blocks Metastasis ...  -  Jul 8, 2008
Science Daily (press release)When the scientists blocked the protein in mice with an antibody, they found that it completely halted the spread of breast cancer to the lungs.

Dyax Corp signs antibody library license agreement with AVEO ...  -  Jul 23, 2008
Trading Markets (press release),Dyax claimed that the company's human antibody phage libraries combine gene fragments from human donors, with strategically designed synthetic DNA and are

Scientists Decipher the Shape of Ebola Virus Protein Bound to ...  -  Jul 10, 2008
Genetic Engineering News (press release),The structure of the antibody together with the viral glycoprotein helps understand the mechanisms by which the molecules assemble on the viral surface and

UPDATE 1-MorphoSys Q2 operating profit jumps 86 pct  -  Jul 28, 2008
ReutersFRANKFURT, July 29 (Reuters) - German biotech company MorphoSys (MORG.DE: Quote, Profile, Research, Stock Buzz) posted an 86 percent jump in second-quarter

YM BIOSCIENCES PRESENTS DATA COMPARING MECHANISM OF ACTION FOR ...  -  Jul 21, 2008
Canada NewsWire (press release),The data describe the unique binding properties of nimotuzumab to EGFR that allows the antibody drug to be effective against cancers without causing the

XOMA Begins Phase 2a Clinical Trial to Evaluate XOMA 629 Topical ...  -  Jul 24, 2008
MarketWatchThe Company's expanding pipeline includes XOMA 052, an anti-IL-1 beta antibody, and XOMA 629, a synthetic antimicrobial peptide compound derived from

Genmab jumps 32 pct on successful drug study  -  Aug 1, 2008
ReutersThe companies said late on Thursday the antibody drug met its goal in the study of difficult-to-treat patients with chronic lymphocytic leukemia (LCC),

Nabi Biopharmaceuticals Announces Positive Interim Results of ...  -  Jul 23, 2008
MarketWatchInterim results from the study indicate that significantly higher anti-nicotine antibody levels can be generated three months earlier and in a much higher

Genmab, GSK CLL Drug Sails Through Pivotal Test  -  Jul 31, 2008
TMCnetOfatumumab (HuMax-CD20), a new generation fully human monoclonal antibody that targets the small loop epitope of the CD20 molecule on B cells,

New Drug Raises Hope For Leukaemia Patients  -  Aug 1, 2008
TheMedGuru,She further added that Genmab was now on its way to filling the first ever marketing application for an antibody. The team was looking forward to continue

Micromet, Inc. To Host Conference Call And Webcast To Discuss ...  -  Jul 29, 2008
ABN Newswire (press release),The BiTE® antibody blinatumomab, also known as MT103, is in a phase 2 clinical trial for the treatment of patients with acute lymphoblastic leukemia and in

Regeneron Reports Second Quarter 2008 Financial and Operating Results  -  Jul 31, 2008
MarketWatchThe first therapeutic antibody to enter clinical development under the collaboration is REGN88, an antibody to the interleukin-6 receptor (IL-6R) that is

Insight into the Current Status and Future Trends of US and ...  -  Jul 21, 2008
MarketWatchAntibody drugs were a $24 billion business in 2007. Although most pharmaceuticals are chemically synthesized small molecules, antibodies are large and

Goodwin Biotechnology's Manufactured Melanin-Binding Antibody Used ...  -  Jul 21, 2008
Ad-Hoc-News (Pressemitteilung),Pain Therapeutics reported that top-line results of the Phase I trialindicate that the antibody binds to melanoma tumor sites, asevidenced by powerful

ARIUS announces second quarter fiscal 2008 financial results  -  Jul 11, 2008
FOXBusinessEngaged Laureate Pharma Inc. for cGMP manufacturing of humanized antibody for Phase 1 clinical supply. A cell line producing the humanized anti-Trop-2

Syntarga Appoints Antibody-Drug Conjugate Expert Dr. Nitin Damle ...  -  Jul 21, 2008
PharmaLive.com (press release),Syntarga is a private biopharmaceutical company developing proprietary Antibody-Drug Conjugate (ADC) technology for the treatment of cancer.

Study Examines Interaction Between HIV, Antibody That Helps Fight ...  -  Jul 17, 2008
Kaiser network.org,HIV gradually depletes the number of functioning B cells, an antibody that fights infections, according to a recent study published in the Journal of

Seattle Genetics Announces Antibody-Drug Conjugate Collaboration ...  -  Jul 8, 2008
Business Wire (press release),Seattle Genetics is a clinical stage biotechnology company focused on the development and commercialization of monoclonal antibody-based therapies for the

Boehringer Ingelheim Gains Access to Additional MorphoSys Technology  -  Jul 8, 2008
FOXBusinessThe RapMAT technology is completely compatible with the HuCAL GOLD antibody library. MorphoSys believes that the use of RapMAT can greatly speed up antibody

The Multiple Myeloma Research Consortium (MMRC) Announces the ...  -  Jul 18, 2008
MarketWatch..."Elotuzumab is a novel antibody that hits a target - CS1 - known to be highly expressed on myeloma cells with a restricted expression on normal cells," says

XOMA 052 Phase 1 Data to be Presented At European Association for ...  -  Jul 15, 2008
MarketWatch...a leader in the discovery and development of antibody therapeutics, today announced that results from two ongoing Phase 1 studies of XOMA 052 in Type 2




archives | news | XML / RSS feed | featured


XML / RSS / Syndication options

mongabay.com features more than 350 RSS feeds to meet your specific area of interest


MONGABAY.COM
Mongabay.com seeks to raise interest in and appreciation of wild lands and wildlife, while examining the impact of emerging trends in climate, technology, economics, and finance on conservation and development (more)

CONTENTS
Rainforests
Tropical Fish
Madagascar
Pictures
Kids' Site
Languages
About
Contact
Archives
Submissions
Newsletter
Contribute


SUPPORT
You can help support mongabay.com by becoming a contributor to keep this site up and running. Thank you for your continued interest in the site.

Help support mongabay.com! Use the link below to buy from Amazon.com!

In Association with Amazon.com





POPULAR PAGES
Rainforests
Amazon deforestation
Deforestation
Deforestation stats
Why rainforests matter
Saving rainforests

Fish
Biotopes
Chemistry
Ecosystem index
Fish conservation

News
Most popular articles
Worth saving?
Forest conservation
Earth Day
Poverty alleviation
Cell phones in Africa
Seniors helping Africa
Saving orangutans in Borneo
Palm oil
Visiting the rainforest

Other Sections
Links
Interview
Mongabay's mission
Recommended Books
Advertising



T-SHIRTS

Madagascar Wildlife
Save Madagascar



Sucking on this frog
may make you insane



In Madagascar there are
lemurs that dance



Don't fall asleep
the sloths will
eat you
<


Canvas shopping bags



Some Blogs:
How to Save the World
Bottleworld
Earth-Info.Net
NewScientist Blog
Gristmill
Journal Watch
Celsias
Cleantech Blog
EcoGeek
EcoSherpa
Earth Blog
GreenOptions
Lime
Plenty Magazine
How the World Works
ScienceBlogs
Sierra Club Compass
The Oil Drum
Treehugger
Triple Pundit
WorldChanging



TOPICS

Africa
Agriculture
Alternative Energy
Amazon
Amphibian Crisis
Amphibians
Animal Behavior
Antarctica
Asia
Australia
Automobiles
Biodiversity
Bioenergy
Biofuels
Biomimicry
Birds
Borneo
Brazil
Bushmeat
California
Carbon Dioxide
Carbon Finance
Carbon Sequestration
Cellulosic Ethanol
China
Climate Change
Congo
Conservation
Coral Reefs
Deforestation
Ecological Services
Endangered Species
Energy
Environment
Environmental Law
Environmental Politics
Ethanol
Extinction
Fires
Fishing
Forests
Fossil Fuels
Green Business
Green Design
Green Energy
Greenland-Arctic
Happy-Upbeat Environmental
Hurricanes
Illegal Logging
India
Indigenous People
Indonesia
Interviews
Invasive Species
Lemurs
Logging
Madagascar
Mammals
Monkeys
New Guinea
Ocean Acidification
Oceans
Oil
Olpc
Orangutans
Palm Oil
Plants
Politics
Pollution
Population
Poverty Alleviation
Primates
Remote Sensing
Renewable Energy
Reptiles
Saving Rainforests
Sea Ice
Sea Levels
Sea Turtles
Sharks
Solar Power
Species Discovery
Strange
Technology
United States
Water
Whales
Wildlife

more



About | Privacy
Copyright Rhett Butler 2009